Phase-III-Studienergebnisse zu neuer Tabletten-Immuntherapie
Crossref DOI link: https://doi.org/10.1007/s15007-018-1657-0
Published Online: 2018-08-04
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Klein, Friederike
Text and Data Mining valid from 2018-08-01
Article History
First Online: 4 August 2018